157
Views
32
CrossRef citations to date
0
Altmetric
Research Article

Comparison of the effects of two different whole body hyperthermia protocols on the distribution of murine leukocyte populations

&
Pages 29-43 | Published online: 09 Jul 2009

References

  • ANSCHER, M. S., SAMULSKI, T. V., DODGE, R., PROSNHZ, L R., and DEwfunsr, M. W., 1997, Combined external beam irradiation and external regional hyperthermia for locally advanced adenocarcinoma of the prostate. International Journal of Radiation Oncology, Biology, Physics, 37, 1059–1065.
  • ASH, S. R., STEINHART, C. R., CURFMAN, M. F., GINGRICH, C. H., SAHLI, D. A., AsH, E. L, FAussET, J. M., and YKIVIN, M. B., 1997, Extracorporeal whole body hyperthermia treatments for HIV infection and AIDS. ASAIO Journal, 43, M830–838.
  • AZOCAR, J., YUNIS, E. J., and ESSEX, M., 1982, Sensitivity of human natural killer cells to hyperthermia. Lancet, 1, 16–17.
  • BLACK, J. D., KOURY, S. T., BANKERT, R. B., and REPASKY, E. A., 1988, Heterogeneity in lymphocyte spectrin distribution: ultrastructural identification of a new spectrin-rich cytoplasmic structure. Journal of Cell Biology, 106, 97–109.
  • BORRELLO, M. A., and PmPPs, R. P., 1996, The B/macrophage cell: an elusive link between CD5+ B lymphocytes and macrophages. Immunology Today, 17, 471–475.
  • BuRD, R., DZIEDZIC, T. S., Xu, Y., CALIGIURI, M. A., SUBJECK, J. R., and REPASKY, E. A., 1998, Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. Journal of Cell Physiology, 177, 137–147.
  • DEL Pozo, M. A., NIETO, M., SERRADOR, J. M., SANCHO, D., VICENTIE-MANZANARES, M., MARITNEZ, C., and SANCHEZ-MADRID, F., 1998, The two poles of the lymphocyte: specialind cell compartments for migration and recruitment. Cell Adhesion & Communication 6, 125–133.
  • DEWEY, W. C., HOPWOOD, L E., SAPARETO, S. A., and GERWECK, L E., 1977, Cellular responses to combinations of hyperthermia and radiation. Radiology, 123, 463–474.
  • DEWHIRST, M. W., PRosNrrz, L, TIIRALE, D., PREscarr, D., CLEGG, S., CHARLES, C., MACFALL, J., ROSNER, G., SAMLTISIU, T, GILLETTE, E., and LARUE, S., 1997, Hyperthermic treatment of malignant diseases: current status and a view toward the future. Seminars in Oncology, 24, 616–625.
  • DI, Y. P., REPASKY, E. A., and SUBJECK, J. R., 1997, Distribution of HSP70, protein kinase C, and spectrin is altered in lymphocytes during a fever-like hyperthermia exposure. Journal of Cellular Physiology, 172, 44–54.
  • DUFF, G. W., 1986, Is fever beneficial to the host: a clinical perspective. Yale Journal of Biology & Medicine, 59, 125–130.
  • EVANS, S. S., FREY, M., SCHLEIDER, D. M., BRUCE, R. A., WANG, W. C., REPASKY, E. A., and APPENHEIMER, M. M., 1998, Regulation of leukocyte-endothelial cell interactions in tumor immunity. The Biology of Tumors 1998, edited by E. Mihich and C. Croce (New York: Plenum Press). pp. 273–286.
  • EVANS, S. S., SCHLEIDER, D. M., BOWMAN, L. A., FRANCIS, M. L., KANSAS, G. S., and BLACK, J. D., 1999, Dynamic association of L-selectin with the lymphocyte cytoskeletal matrix. The Journal of Immunology, 162, 3615–3624.
  • GERAD, H., EGORIN, M. J., WHITACRE, M., VAN ECHO, D. A., and AISNER, J., 1983, Renal failure and platinum pharmacokinetics in three patients treated with cis-diamminedichloroplatinum(II) and whole-body hyperthermia. Cancer Chemotherapy & Pharmacology, 11, 162–166.
  • HARRIS, J. W., and MENES, J. J., 1978, Effects of hyperthermia on the production and activity of primary and secondary cytolytic T-lymphocytes in vitro. Cancer Research, 38, 1120–1126.
  • HAUCK, M. L., PRICE, G. S., OGILVIE, G. K., JOHNSON, J., GILLETTE, E. L., 11-1RALL, D. E., DEWHIRST, M. W., and PAGE, R. L., 1996, Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma. International Journal of Hyperthermia, 12, 309–320.
  • HUANG, Y. H., HAEGERSTRAND, A., and FROS1EGARD, J., 1996, Effects of in vitro hyperthermia on proliferative responses and lymphocyte activity. Clinical & Experimental Immunology, 103, 61–66.
  • HUGHES, C. S., REPASKY, E. A., BANRERT, R. B., JOHNSON, R. J., and SUBJECK, J. R., 1987, Effects of hyperthermia on spectrin expression patterns of murine lymphocytes. Radiation Research, 112, 116–123.
  • JAMPEL, H. D., DUFF, G. W., GERSHON, R. K., ATIGNs, E., and DURUM, S. K., 1983, Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. Journal of Experimental Medicine, 157, 1229–1238.
  • KAPPEL, M., STADEAGER, C., rIVEDE, N., GALI30, H., and PEDERSEN, B. K., 1991, Effects of in vivo hyperthermia on natural killer cell activity, in vitro proliferative responses and blood mononuclear cell subpopulations. Clinical & Experimental Immunology, 84, 175–180.
  • KLUGER, M. J., KOZAK, W., CONN, C. A., LEON, L. R., and SOSZYNSKI, D., 1996, The adaptive value of fever. Infectious Disease Clinics of North America, 10, 1–20.
  • LEFOR, A. T, FOSIER, C. E., III, SARTOR, W., ENGBRECHT, B., FABIAN, D. F., and SILVERMAN, D., 1994, Hyperthermia increases intercellular adhesion molecule-1 expres-sion and lymphocyte adhesion to endothelial cells. Surgery, 116, 214–221.
  • LINDHOLM, C. E., KJEILEN, E., NILSSON, P., WEBER, L., and HILL, S., 1995, Prognostic factors for tumour response and skin damage to combined radiotherapy and hyperthermia in superficial recurrent breast carcinomas. International Journal of Hyperthermia, 11, 337–340.
  • LU, L, SHEN, R. N., Zuou, S. Z., Wu, B., Km, Y. J., UN, Z. H., RuscETn, S., RALPH, P., and BROXMEYER, H. E., 1991, Efficacy of recombinant human macrophage colony-stimulating factor in combination with whole-body hyperthermia in the treatment of mice infected with the polycythemia-inducing strain of the Friend virus complex. Experimental Hematology, 19, 804–809.
  • MAISUDA, H., SIREBEL, F. R., KANEKo, T., DANHAUSER, L L., JENIUNS, G. N., 'IbyoTA, N., and BULL, J. M., 1997, Long duration-mild whole body hyperthermia of up to 12 hours in rats: feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: implications for adjuvant therapy. International Journal of Hyperthermia, 13, 89–98.
  • MYRZINGER, P., 1994, Tolerance, danger, and the extended family. Annual Review of Immunology, 12, 991–1045.
  • NAILAS, G. G., TANNIERES, M. L., and LENNON, J. F., 1971, Direct measurement of leukocyte motility: effects of pH and temperature. Proceedings of the Society for Experimental Biology & Medicine, 138, 350–352.
  • OHNO, S., SIREBEL, F. R., SIEMENS, L. C., SIDDIK, Z. H., BABA, H., MAKINO, M., KHOKHAR, A. R., and BuLL, J. M., 1993, Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats. British Journal of Cancer, 68, 469–474.
  • OVERGAARD, J., GONZALEZ, D. G., HULSHOF, M. C. C. M., ARCANGELI, G., DAL-1, O., MELIA, O., and BENTZEN, S. M., 1996, Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology. International Journal of Hyperthermid 12, 3–20.
  • ROBERIS, N. J., JR., 1991, Impact of temperature elevation on immunologic defenses. Reviews of Infectious Diseases, 13, 462–472.
  • ROBINS, H. I., HUGANDER, A., and COHEN, J. D., 1989, Whole body hyperthermia in the treatment of neoplastic disease. Radiologic Clinics of North America, 27, 603–610.
  • ROBINS, H. I., OLEIRE, D. F., GROSEN, E., and SPRIGGS, D., 1997, Rationale and clinical status of 41.8°C systemic hyperthermia tumor necrosis factor, and melphalan for neoplastic disease. Anticancer Research, 17, 2891–2894.
  • SAKAGUCHI, Y., MAIUNO, M., KANEKO, T., SIEMENS, L C., SIREBEL, F. R., DANHAUSER, L L., JENIUNS, G. N., and BuEE, J. M., 1994, Therapeutic efficacy of long duration—low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats. Cancer Research, 54, 2223–2227.
  • SALZMAN, G. C., MULLANEY, P. F., and PRICE, B. J., 1979, Light scattering approaches to cell cha acterization. Flow Cytometry and Cell Sorting 1979, edited by M. R. Melamed, P. F. Mullaney and M. L. Mendelsohn (New York: John Wiley and Sons), pp. 104–124.
  • SHEN, R. N., HORNBACK, N. B., SHIDNIA, H., SnuPE, R. E., and BRAHMI, Z., 1987, Whole-body hyperthermia decreases lung metastases in lung tumor-bearing mice, possibly via a mechanism involving natural killer cells. Journal of Clinical Immunology, 7, 246–253.
  • SEWN, R. N., HORNBACK, N. B., SHIDNIA, H., Wu, B., Lu, L, and BRoxmEYER, H. E., 1991, Whole body hyperthermia: a potent radioprotector in vivo. International Journal of Radiation Oncology, Biology, Physics, 20, 525–530.
  • SMITH, J. B., KNOWLION, R. P., and AGARWAL, S. S., 1978, Human lymphocyte responses are enhanced by culture at 40°C. Journal of Immunology, 121, 691-694. 'Il)-YoTA, N., SIREBEL, F. R., SIEMENS, L. C., MAISUDA, H., and BULL, J. M., 1997, Long-duration, mild whole body hyperthermia with cisplatin: tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma. International Journal of Hyperthermia, 13, 497–506.
  • VAUGHN, L. K., BERNHEIM, H. A., and KLUGER, M. J., 1974, Fever in the lizard Dipsosaurus dorsalis. Nature, 252, 473–474.
  • WANG, W. C., GOLDMAN, L. M., SCHLEIDER, D. M., APPENHEIMER, M. M., SUBJECK, J. R., REPASKY, E. A., and EVANS, S. S., 1998, Fever-range hyperthermia enhances L-selec-tin-dependent adhesion of lymphocytes to vascular endothelium. Journal of Immunology, 160, 961–969.
  • WANG, X.-Y., OgIBERG, J. R., and REPASKY, E. A., 1999, Effect of fever-like whole body hyperthermia on lymphocyte spectrin distribution, protein kinase C activity and uropod formation. Journal of Immunology, 162, 3378–3387.
  • WIEDEMANN, G. J., ROBINS, H. I., KAISCHINSKI, D. M., MENIZEL, M., OLEIRE, F. D., Kurz, M., and WAGNER, T, 1997, Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. Anticancer Research, 17, 2899–2902.
  • WONDERGEM, J., STREBEL, F. R., SIDDIK, Z. H., NEWMAN, R. A., and BULL, J. M., 1988, The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaC1 concentration of the vehicle. International Journal of Hyperthermia, 4, 643–654.
  • WONDERGEM, J., STREBEL, F. R., SIEPHENS, L C., SIDDIK, Z. H., and BULL, J. M., 1995, Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat. International Journal of Hyperthermiu 11, 37–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.